Journal for immunotherapy of cancer

Framework humanization optimizes potency of anti-CD72 nanobody CAR-T cells for B-cell malignancies.

Journal for immunotherapy of cancer

Temple WC, Nix MA, Naik A, Izgutdina A, Huang BJ, Wicaksono G, Phojanakong P, Serrano JAC, Young EP, Ramos E, Salangsang F, Steri V, Xirenayi S, Hermiston M, Logan AC, Stieglitz E, Wiita AP

Leveraging immune resistance archetypes in solid cancer to inform next-generation anticancer therapies.

Journal for immunotherapy of cancer

Anderson KG, Braun DA, Buqué A, Gitto SB, Guerriero JL, Horton B, Keenan BP, Kim TS, Overacre-Delgoffe A, Ruella M, Triplett TA, Veeranki O, Verma V, Zhang F

676 Altered circulating myeloid states associated with anti-PD-1 resistance induce T cell paralysis in human biliary cancer.

Journal for immunotherapy of cancer

Bridget Keenan, Elizabeth McCarthy, Arielle Ilano, Hai Yang, Li Zhang, Kathryn Allaire, Zenghua Fan, Tony Li, David Lee, Yang Sun, Alexander Cheung, Hewitt Chang, Brenna Sheldon, Robin Kelley, Chun Jimmie Ye, Lawrence Fong

99 T cell immunotherapies trigger neutrophil activation to eliminate tumor antigen escape variants.

Journal for immunotherapy of cancer

Daniel Hirschhorn, Sadna Budhu, David Schröder, Lukas kraehenbuehl, Anne-Laurent Flammar, Andrew Chow, Isabell Schulze, Sara Schad, Jacob Ricca, Billel Gasmi, Olivier De Henau, Levi Mangarin, David Redmond, Czrina Cortez, Cailian Liu, Aliya Holland, Mathieu Gigoux, Asrhi Arora, Katherine Panageas, Gabrielle Rizzuto, Jean Albrengues, Mikala Egeblad, Jedd Wolchok, Taha Merghoub

PD-1+CXCR5-CD4+ Th-CXCL13 cell subset drives B cells into tertiary lymphoid structures of nasopharyngeal carcinoma.

Journal for immunotherapy of cancer

Li JP, Wu CY, Chen MY, Liu SX, Yan SM, Kang YF, Sun C, Grandis JR, Zeng MS, Zhong Q